Suchergebnisse - "Binder, Adam F"

PubPharm (29)

1

Patient and caregiver perceptions of the possibility of home blood transfusions

enthalten in: Transfusion | 2024

von Binder, A. | Hossain, A. | Doshi, R. | +5

2

Utility of Respiratory Pathogen Panels in the Outpatient Oncology Setting

enthalten in: American journal of medical quality : the official journal of the American College of Medical Quality | 2023

von Gripp, E. | Hess, B. | Binder, A.

3

Racial and Ethnic Differences in the Use of Electronic Medical Record Messaging Among Patients With Breast Cancer : A Quality Improvement Study

enthalten in: Clinical breast cancer | 2023

von Conroy, M. | Kamaraju, S. | Powell, M. | +8

4

Impacting T-cell fitness in multiple myeloma : potential roles for selinexor and XPO1 inhibitors

enthalten in: Frontiers in immunology | 2023

von Binder, A. | Walker, C. | Mark, T. | +1

5

Delay in Time to Antibiotics for De Novo Inpatient Neutropenic Fever May Not Impact Overall Survival for Patients With a Cancer Diagnosis

enthalten in: American journal of medical quality : the official journal of the American College of Medical Quality | 2023

von Villars, J. | Gardner, C. | Zhan, T. | +1

6

Optimizing Utilization of Blood Products in the Hematologic Malignancy Clinic : Less Is More

enthalten in: JCO oncology practice | 2022

von Binder, A. | Loos, K. | Xu, A. | +4

7

COVID-19 Pandemic Influence on Medical Oncology Provider Perceptions of Telehealth Video Visits

enthalten in: JCO oncology practice | 2022

von Handley, N. | Heyer, A. | Granberg, R. | +7

8

Trainee-Led Quality Improvement Project to Improve Fertility Preservation Counseling for Patients With Cancer

enthalten in: JCO oncology practice | 2022

von Sena, L. | Sedhom, R. | Scott, S. | +14

9

Development of the Oncology Opportunity Cost Assessment Tool : Item Generation and Content Validity Testing

enthalten in: JCO oncology practice | 2022

von Handley, N. | Binder, A. | Heyer, A. | +5

10

Antibody Response to SARS-CoV-2 Vaccination in Patients With Lymphoproliferative Disorders and Plasma Cell Dyscrasias : Anti-Lymphoma Therapy as a Predictive Biomarker of Response to Vaccination

enthalten in: Frontiers in oncology | 2022

von Gung, C. | McGuire, R. | George, M. | +7